Drug profile · INN
naratriptan hydrochloride
NARATRIPTAN
naratriptan hydrochloride (NARATRIPTAN) is a serotonin 1b (5-ht1b) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — naratriptan hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
naratriptan hydrochloride (NARATRIPTAN) is a serotonin 1b (5-ht1b) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1b (5-HT1b) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1B
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is naratriptan hydrochloride?
naratriptan hydrochloride (NARATRIPTAN) is a serotonin 1b (5-ht1b) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naratriptan hydrochloride?
NARATRIPTAN is a marketed brand name for naratriptan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naratriptan hydrochloride?
naratriptan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.